Evidence map›Paper›PMID 36329344›Full record

ArticleCurrent microbiology2022

Bio-Prospecting of Endospore-Based Formulation of Bacillus sp. BST18 Possessing Antimicrobial Genes for the Management of Soil-Borne Diseases of Tomato.

Sankarasubramanian Harish

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sankarasubramanian HarishDepartment of Plant Pathology, Tamil Nadu Agricultural University, Coimbatore, 641 003, Tamil Nadu, India. harish.s@tnau.ac.in.ORCID http://orcid.org/0000-0001-5703-9887
Tamil Nadu Agricultural University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tomato is affected by various diseases which cause economical loss to the farming community. In the present study, twenty isolates of Bacillus sp. were isolated from the rhizosphere of tomato and screened against soil-borne pathogens viz., Pythium aphanidermatum No.5, Fusarium oxysporum f. sp. lycopersici No. FOL-8, and Sclerotium rolfsii No. S-MK in tomato. The results revealed that three Bacillus sp. viz., BST8, BST18, and BST19 were promising in reducing the mycelial growth of the pathogens (up to 48% reduction) when compared to control under in vitro. The isolates possessed antimicrobial peptide genes which were detected through PCR. Novel compounds and secondary metabolites responsible for antifungal action were identified through GC-MS and FTIR analysis. Endospores have been isolated from the Bacillus sp. BST18 and standardized for the development of formulation. Pot culture experiment revealed sequential application of endospore-based bioformulation as seed treatment, (10 ml/kg), seedling dip (10 ml/lit), soil application on 30 days (100 ml/pot) along with foliar spray (0.2%) on 60 days recorded the lowest disease incidence of wilt (9.5%), and collar rot (11.5%) as against 65.5% and 75%, respectively, in the inoculated control. Field experiments revealed sequential application of endospore-based formulation of Bacillus sp. BST 18 as seed treatment, (10 ml/kg), seedling dip (10 ml/lit), soil application (400 ml/acre) at 30 days after transplantation (DAT) along with foliar spray (0.2%) on 60 DAT recorded the lowest wilt disease incidence of 15.97 &17.07 percent as against 49.77 & 51.10 percent in the control.

Indexed as

BacillusFusariumSolanum lycopersicumAntifungal AgentsPlant DiseasesSeedlingsSoilAntifungal AgentsSoil

Identifiers

PMID36329344
OpenAlexW4308367808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.